Tebufenpyrad
Tebufenpyrad Basic information
- Product Name:
- Tebufenpyrad
- Synonyms:
-
- TEBUFENPYRAD
- PYRANICA
- OSCAR
- 1h-pyrazole-5-carboxamide,4-chloro-n-((4-(1,1-dimethylethyl)phenyl)methyl)-3-e
- 4-chloro-n-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1h-pyrazol
- 4-chloro-n-((4-(1,1-dimethylethyl)phenyl)methyl)-3-ethyl-1-methyl-1h-pyrazole-5-carboxamid
- ac801757
- comanché
- CAS:
- 119168-77-3
- MF:
- C18H24ClN3O
- MW:
- 333.86
- EINECS:
- 242-070-7
- Product Categories:
-
- Agro-Products
- Aromatics
- Herbicide
- INSECTICIDE
- Heterocycles
- Mol File:
- 119168-77-3.mol
Tebufenpyrad Chemical Properties
- Melting point:
- 61-62°
- Boiling point:
- 468.4±45.0 °C(Predicted)
- Density
- 1.1639 (rough estimate)
- refractive index
- 1.5790 (estimate)
- storage temp.
- 0-6°C
- solubility
- Benzene (Slightly), DMSO (Slightly), Methanol (Slightly)
- pka
- 13.19±0.46(Predicted)
- BRN
- 8636471
- LogP
- 4.610
- CAS DataBase Reference
- 119168-77-3(CAS DataBase Reference)
- EPA Substance Registry System
- Tebufenpyrad (119168-77-3)
Safety Information
- Hazard Codes
- Xn
- Risk Statements
- 22
- Safety Statements
- 36
- RIDADR
- 2588
- WGK Germany
- 3
- RTECS
- UQ6276400
- HazardClass
- 6.1(b)
- PackingGroup
- III
- HS Code
- 29331990
- Hazardous Substances Data
- 119168-77-3(Hazardous Substances Data)
- Toxicity
- LD50 in male, female rats (mg/kg): 595, 997 orally; >2000, >2000 dermally; LC50 in male rats (mg/m3): 2660 by inhalation (Inoue, Fukuchi)
Tebufenpyrad Usage And Synthesis
Chemical Properties
Tan Solid
Uses
Tebufenpyrad is a pyrazole acaricide and insecticide commonly used in commercial greenhouses.
Uses
Acaricide.
Definition
ChEBI: Tebufenpyrad is a pyrazole acaricide and a pyrazole insecticide. It has a role as a mitochondrial NADH:ubiquinone reductase inhibitor.
Metabolic pathway
By incubation of tebufenpyrad with rat liver
homogenate, tebufenpyrad undergoes
biotransformation to yield the major metabolites N-(4-
tert-butylbenzyl)-4-chloro-3-(1-hydroxyethyl)-1-
methylpyrazole-5-carboxamide via hydroxylation of the
w-1-carbon of the ethyl group and N-[4-(1-carboxy-1-
methylethyl)benzyl]-4-chloro-3-ethyl-1-methylpyrazole-
5-carboxamide via oxidation of the methyl group in the
tert-butyl moiety to the carboxylic acid derivatives.
When the rat is orally dosed tebufenpyrad, the major
metabolism pathway is via both hydroxylation and
oxidation reactions to yield N-[4-(1-carboxy-1-
methylethyl)benzyl]-4-chloro-3-(1-hydroxyethyl)-1-
methylpyrazole-5-carboxamide which is mainly
excreted in the urine.
Tebufenpyrad Preparation Products And Raw materials
Raw materials
TebufenpyradSupplier
- Tel
- 021-50182298 021-50180596
- sales@boylechem.com
- Tel
- 010-82848833 400-666-7788
- jkinfo@jkchemical.com
- Tel
- 13306234115
- jszyzj@zhongyichem.com
- Tel
- 001-857-928-2050 or 1-888-588-9418
- sales@chemreagents.com
- Tel
- 021-50135380
- shchemsky@sina.com
Tebufenpyrad(119168-77-3)Related Product Information
- Fenpyroximate
- Fenbutatin oxide
- Bromopropylate
- FLUFENZINE
- Propargite
- ETOXAZOLE
- ACEQUINOCYL
- Fenazaquin
- Clofentezine
- Azocyclotin
- Benzoximate
- Machette
- 1,3-DIMETHYL-1H-PYRAZOLE-5-CARBOXAMIDE
- (1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHYLAMINE
- Tebufenpyrad
- N-[(1,3-DIMETHYL-1H-PYRAZOL-5-YL)METHYL]-N-METHYLAMINE
- 4-CHLORO-2-METHYL-2 H-PYRAZOLE-3-CARBALDEHYDE
- 1H-Pyrazole-3-carboxamide, N-ethyl-5-methyl-